[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"goiter-malignant\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:goiter-malignant":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":29,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":4},"100557363",false,"NCT06537141","Role of Embolization of Thyroid Arteries as a Treatment for Different Thyroid Disorders","Role of Selective Embolization of Thyroid Arteries (SETA) as an Adjunctive or Definitive Treatment for Different Thyroid Disorders","Inclusion Criteria:\n\nA- diffuse and Nodular goiter:\n\nB-Toxic goiter:\n\nC-Thyroid cancer:\n\nExclusion Criteria:\n\nA. Significant bleeding diathesis. B. Contraindication for contrast media (renal impairment or allergy). C. Severe atherosclerotic disease prevent arterial catheterization. D. Refusal of signing a consent","ALL","18 Years",{"count":18,"type":19},20,"ESTIMATED","INTERVENTIONAL",[22],"NA","To investigate the safety and efficacy of selective embolization of thyroid arteries (SETA) as adjunctive or definitive treatment in different thyroid disorders",[25,26,27,28],"Graves Disease","Goiter, Nodular","Goiter Malignant","Goiter Diffuse",[30],"Embolization of thyroid arteries","NOT_YET_RECRUITING","2024-08-01",{"date":34,"type":35},"2024-08-05","ACTUAL",{"date":37,"type":19},"2024-08-10",{"date":39,"type":19},"2026-07-30",{"name":41,"class":42},"Assiut University","OTHER",""]